Literature DB >> 20844987

Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.

Mahalakshmi Palani1, Sabarinathan Devan, R Arunkumar, A J Vanisree.   

Abstract

Gliomas are the most common primary brain tumors in India. The main epigenetic modification in glioma is aberrant DNA methylation that is now renowned to be a common hallmark of brain tumors. This study was designed to determine the frequency of aberrant CpG island methylation in the promoter regions of p21 and p73 in different grades of glioma and to explore their respective chromosomal aberrations. Total of 160 patients with histologically confirmed grades of glioma (I, II, III, and IV) were included in the study. DNA samples from blood and brain tissues, including benign lesions were subjected to sodium bisulfite conversion and hypermethylation detection using methylation-specific PCR followed by RT-PCR. Western blotting was also carried out for p21 and its related protein, p53. A total of 124 of 160 glioma samples (77.5%) displayed CpG island hypermethylation of both p73, p21 genes associated with the loss of mRNA expression (P < 0.001) and the loss of protein expressions (p53 independent p21 expression). p73 gene showed increased methylation frequency in all grades, 40 of 60 (66%) glioblastomas and 16 of 30 (53.3%) anaplastic astrocytoma, 10 of 20(50%) oligodendrogliomas, 8 of 20 (40%) ependymoma, and low-grade glioma 6 of 20 (30%). The percentage of methylation significantly well correlated with the overall survival and also with chromosomal loss. Thus, the studied glioma patients among south Indians showed a high frequency of aberrant methylation with varied chromosomal signatures in different grades, playing a role in aggressiveness and characterization of a particular grade, the appreciation of which might help for designing a specific therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844987     DOI: 10.1007/s12032-010-9671-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  A gene hypermethylation profile of human cancer.

Authors:  M Esteller; P G Corn; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

2.  Absence of mutation of the p73 gene in astrocytic neoplasms.

Authors:  M E Alonso; M J Bello; J Lomas; P Gonzalez-Gomez; D Arjona; J M De Campos; M Gutierrez; A Isla; J Vaquero; J A Rey
Journal:  Int J Oncol       Date:  2001-09       Impact factor: 5.650

Review 3.  Epigenetic diagnostics of cancer--the application of DNA methylation markers.

Authors:  Jaroslaw Paluszczak; Wanda Baer-Dubowska
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

4.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.

Authors:  P G Corn; S J Kuerbitz; M M van Noesel; M Esteller; N Compitello; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

Review 5.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

6.  Alterations in tumour suppressor gene p53 in human gliomas from Indian patients.

Authors:  Poornima Phatak; S Kalai Selvi; T Divya; A S Hegde; Sridevi Hegde; Kumaravel Somasundaram
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

7.  Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.

Authors:  A Böhnke; F Westphal; A Schmidt; R A El-Awady; J Dahm-Daphi
Journal:  Int J Radiat Biol       Date:  2004-01       Impact factor: 2.694

8.  Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.

Authors:  Jian Yu; Hongyu Zhang; Jun Gu; Song Lin; Junhua Li; Wei Lu; Yifei Wang; Jingde Zhu
Journal:  BMC Cancer       Date:  2004-09-14       Impact factor: 4.430

9.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Genetic and epigenetic changes in p21 and p21B do not correlate with resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancer.

Authors:  Vidar Staalesen; Beryl Leirvaag; Johan Richard Lillehaug; Per Eystein Lønning
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

View more
  5 in total

1.  Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.

Authors:  Mahalakshmi Palani; R Arunkumar; Arrambakam Janardhanam Vanisree
Journal:  Neuromolecular Med       Date:  2014-05-20       Impact factor: 3.843

Review 2.  A critical overview of long non-coding RNA in glioma etiology 2016: an update.

Authors:  Yuan-Feng Gao; Zhi-Bin Wang; Tao Zhu; Chen-Xue Mao; Xiao-Yuan Mao; Ling Li; Ji-Ye Yin; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2016-09-15

3.  Genome-wide study of DNA methylation alterations in response to diazinon exposure in vitro.

Authors:  Xiao Zhang; Andrew D Wallace; Pan Du; Simon Lin; Andrea A Baccarelli; Hongmei Jiang; Nadereh Jafari; Yinan Zheng; Hehuang Xie; Marcelo Bento Soares; Warren A Kibbe; Lifang Hou
Journal:  Environ Toxicol Pharmacol       Date:  2012-08-01       Impact factor: 4.860

Review 4.  Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.

Authors:  Bryant England; Tiangui Huang; Michael Karsy
Journal:  Tumour Biol       Date:  2013-06-05

Review 5.  The p53 Pathway in Glioblastoma.

Authors:  Ying Zhang; Collin Dube; Myron Gibert; Nichola Cruickshanks; Baomin Wang; Maeve Coughlan; Yanzhi Yang; Initha Setiady; Ciana Deveau; Karim Saoud; Cassandra Grello; Madison Oxford; Fang Yuan; Roger Abounader
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.